Cleared Traditional

K181261 - Curiteva Cervical Interbody Fusion System

K181261 is the FDA 510(k) clearance for Curiteva Cervical Interbody Fusion System by Curiteva, LLC. It is a Class 2 Orthopedic device (product code ODP) cleared through the Traditional 510(k) pathway after a 59-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2018
Decision
59d
Days
Class 2
Risk

K181261 is an FDA 510(k) clearance for the Curiteva Cervical Interbody Fusion System. Classified as Intervertebral Fusion Device With Bone Graft, Cervical (product code ODP), Class II - Special Controls.

Submitted by Curiteva, LLC (Tanner, US). The FDA issued a Cleared decision on July 9, 2018 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Curiteva, LLC devices

Submission Details

510(k) Number K181261 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 11, 2018
Decision Date July 09, 2018
Days to Decision 59 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 122d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code ODP Intervertebral Fusion Device With Bone Graft, Cervical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - ODP Intervertebral Fusion Device With Bone Graft, Cervical

All 215
Devices cleared under the same product code (ODP) and FDA review panel - the closest regulatory comparables to K181261.
ACCUFUSE Cervical System
K181471 · Absolute Advantage Medical, LLC · Aug 2018
ATEC Cervical Spacer System
K181435 · Alphatec Spine, Inc. · Aug 2018
CxHA PEEK Cervical IBF System
K181115 · Innovasis, Inc. · Jul 2018
Tyber Medical PT Interbody Spacer System
K180590 · Tyber Medical, LLC · Jul 2018
HD LifeSciences Cervical IBFD System
K180364 · Hd Lifesciences, LLC · Jun 2018
MONET™ Anterior Cervical Interbody Fusion Cage System
K172788 · Ctl Medical Corporation · Jun 2018